Avita Capex To Depreciation vs Operating Cash Flow Per Share Analysis
RCEL Stock | USD 13.34 0.47 3.65% |
Avita Medical financial indicator trend analysis is way more than just evaluating Avita Medical prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Avita Medical is a good investment. Please check the relationship between Avita Medical Capex To Depreciation and its Operating Cash Flow Per Share accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Avita Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For more information on how to buy Avita Stock please use our How to buy in Avita Stock guide.
Capex To Depreciation vs Operating Cash Flow Per Share
Capex To Depreciation vs Operating Cash Flow Per Share Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Avita Medical Capex To Depreciation account and Operating Cash Flow Per Share. At this time, the significance of the direction appears to have very week relationship.
The correlation between Avita Medical's Capex To Depreciation and Operating Cash Flow Per Share is 0.24. Overlapping area represents the amount of variation of Capex To Depreciation that can explain the historical movement of Operating Cash Flow Per Share in the same time period over historical financial statements of Avita Medical, assuming nothing else is changed. The correlation between historical values of Avita Medical's Capex To Depreciation and Operating Cash Flow Per Share is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capex To Depreciation of Avita Medical are associated (or correlated) with its Operating Cash Flow Per Share. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Cash Flow Per Share has no effect on the direction of Capex To Depreciation i.e., Avita Medical's Capex To Depreciation and Operating Cash Flow Per Share go up and down completely randomly.
Correlation Coefficient | 0.24 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Capex To Depreciation
The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.Operating Cash Flow Per Share
A measure of the cash generated from a company's normal business operations per share, indicating how much cash is generated from a company's business operations on a per-share basis.Most indicators from Avita Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Avita Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Avita Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For more information on how to buy Avita Stock please use our How to buy in Avita Stock guide.At this time, Avita Medical's Selling General Administrative is quite stable compared to the past year. Tax Provision is expected to rise to about 69.3 K this year, although the value of Sales General And Administrative To Revenue will most likely fall to 0.74.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 11.3M | 41.7M | 42.4M | 44.5M | Total Revenue | 14.3M | 50.6M | 50.1M | 52.7M |
Avita Medical fundamental ratios Correlations
Click cells to compare fundamentals
Avita Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Avita Medical fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Other Current Liab | 455.5K | (1.4M) | (957K) | 6.9M | 338K | 321.1K | |
Total Current Liabilities | 4.4M | 11.2M | 7.7M | 15.7M | 13.2M | 13.9M | |
Retained Earnings | (128.7M) | (282.4M) | (194.9M) | (385.7M) | (298.0M) | (283.1M) | |
Net Receivables | 2.1M | 3.5M | 2.4M | 5.2M | 7.7M | 8.0M | |
Other Stockholder Equity | 29.8M | 375.5M | 259.2M | 499.2M | 574.0M | 602.7M | |
Total Current Assets | 24.2M | 113.6M | 78.4M | 128.5M | 104.0M | 109.2M | |
Inventory | 740.8K | 1.6M | 1.1M | 3.1M | 5.6M | 5.9M | |
Other Current Assets | 1.1M | 1.7M | 990K | 3.6M | 4.2M | 4.4M | |
Accounts Payable | 3.9M | 6.3M | 4.3M | 4.4M | 3.8M | 4.0M | |
Other Liab | 471K | 435K | 1.6M | 2.5M | 2.9M | 3.0M | |
Net Tangible Assets | 20.6M | 72.0M | 115.2M | 84.3M | 96.9M | 51.6M | |
Property Plant Equipment | 1.3M | 3.7M | 2.9M | 2.1M | 2.4M | 1.7M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Avita Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For more information on how to buy Avita Stock please use our How to buy in Avita Stock guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avita Medical. If investors know Avita will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avita Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.23) | Revenue Per Share 2.335 | Quarterly Revenue Growth 0.432 | Return On Assets (0.45) | Return On Equity (1.52) |
The market value of Avita Medical is measured differently than its book value, which is the value of Avita that is recorded on the company's balance sheet. Investors also form their own opinion of Avita Medical's value that differs from its market value or its book value, called intrinsic value, which is Avita Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avita Medical's market value can be influenced by many factors that don't directly affect Avita Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avita Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Avita Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avita Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.